Date Name Title Filing Type Shares Traded Price Range Total Held
Nov 02, 2026 Director, President and CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 62,928 -- 62,928
Nov 02, 2026 Director, President and CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 38,265 -- 101,193
Nov 02, 2026 Director, President and CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 62,928 -- 62,928
Oct 29, 2026 EVP and CFO Form 4 Open market or private sale of non-derivative or derivative security 23,615 $12.27 280,461
Oct 28, 2026 EVP and CFO Form 4 Open market or private sale of non-derivative or derivative security 1,720 $12.17 304,076
Jul 30, 2026 SVP Quality and Regulatory Form 4 Open market or private sale of non-derivative or derivative security 23,370 $14.72 64,745
Jul 22, 2026 SVP/GM, Vascular Access Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 6,466 -- 111,006
Jul 22, 2026 SVP/GM, Vascular Access Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 2,330 $13.82 108,676
Jul 22, 2026 SVP/GM, Vascular Access Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 22,768 -- --
Jul 22, 2026 Director, President and CEO Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 52,358 -- 889,176
 For recent transactions, including derivative transactions, see our Section 16 SEC filings page.